Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of WCK 771 in Healthy Volunteers
NCT05640531Phase 1Completed
- Sponsor
- Wockhardt
- Start
- Dec 2011
- Primary completion
- Feb 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in bacterial infection and acute bacterial skin and skin structure infection (ABSSSI) comparing WCK 771 with Placebo (2 arms). Primary endpoints: Safety and tolerability of multiple doses of WCK 771 at Day 12 and Pharmacokinetics of multiple doses of WCK 771 at Day 5. Started Dec 2011; status: completed.
02
Drugs
levonadifloxacin
03
Conditions
bacterial infectionacute bacterial skin and skin structure infection (ABSSSI)
Beyond the preview
Go deeper on NCT05640531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05640531.